Chien Jennifer Insider Trades

Insider Trading History

Track insider trading activity for Chien Jennifer. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Evp, Head Of North America
Holding Value $433k 4,940 shares
Last Trade
Feb 14, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.1k 635 shares
$26.87
$87.61
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Evp, Head Of North America
Holding Value $356k 4,062 shares
Last Trade
Feb 11, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$56.4k 2,031 shares
$27.77
$87.61
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Evp, Head Of North America
Holding Value $488k 5,575 shares
Last Trade
Feb 11, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$56.4k 2,031 shares
$27.77
$87.61
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Evp, Head Of North America
Holding Value $310k 3,544 shares
Last Trade
Feb 09, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$33.1k 1,204 shares
$27.51
$87.61
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Evp, Head Of North America
Holding Value $312k 3,556 shares
Last Trade
Feb 09, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$33k 1,192 shares
$27.66
$87.61
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Evp, Head Of North America
Holding Value $903k 10,312 shares
Last Trade
Feb 09, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$95.1k 3,438 shares
$27.66
$87.61
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Evp, Head Of North America
Holding Value $416k 4,748 shares
Last Trade
Feb 09, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$95.1k 3,438 shares
$27.66
$87.61
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Evp, Head Of North America
Holding Value $4.11M 46,900 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.78M 64,950 shares
$27.35
$87.61
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Evp, Head Of North America
Holding Value $115k 1,310 shares
Last Trade
Feb 15, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.9k 722 shares
$6.79
$87.61
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Evp, Head Of North America
Holding Value $534k 6,093 shares
Last Trade
Feb 11, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.5k 2,032 shares
$6.13
$87.61
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Evp, Head Of North America
Holding Value $178k 2,032 shares
Last Trade
Feb 11, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.5k 2,032 shares
$6.13
$87.61
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Evp, Head Of North America
Holding Value $7.23M 82,500 shares
Last Trade
Feb 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$655k 96,250 shares
$6.80
$87.61
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Evp, Head Of North America
Holding Value $4.27M 48,750 shares
Last Trade
Feb 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.74M 56,875 shares
$30.66
$87.61
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Evp, Head Of North America
Holding Value $8.76M 100,000 shares
Last Trade
Nov 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.43M 100,000 shares
$24.29
$87.61
Krystal Biotech
Krystal Biotech KRYS
Chief Commercial Officer
Holding Value $38.5M 125,000 shares
Last Trade
Jan 31, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.53M 125,000 shares
$52.26
$307.79

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up